Is a complete AURA research report available?

No complete published report is available for Aura Biosciences, Inc. (AURA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · USD

$7.11

+0.10 (+1.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AURA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	784.2M
Net income (ttm)	-112.4M
EPS (ttm)	-$1.74
Shares out	110.3M
Volume	292,923
Beta	0.40
Price target	$18.8	+164.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -112.4M
EPS (ttm): -$1.74
Market cap: 784.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AURA indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001501796
Company name	Aura Biosciences, Inc.
Country	United States
Country code	US
Cusip	05153U107
Employees	113
Employees Change	4%
Employees Change Percent	3.67
Enterprise value	$686.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-29
Isin	US05153U1079
Last refreshed	2026-07-31
Market cap	$784.2M
Market cap category	Small-Cap
Price	$7.11
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	AURA
Website	https://www.aurabiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.33%
FCF yield	-11.69%
P/B ratio	4.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-112.4M
Net Income Growth Years	0%
Profit Per Employee	$-994,628
ROA	-50.59
Roa5y	-26.7
ROCE	-98.06
ROE	-95.57
Roe5y	-46.13
ROIC	-54.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	4.72%
Cagr3y	-15.49%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$137.7M
Cash	$114.7M
Current Assets	$118.5M
Current Liabilities	$16.7M
Debt	$17M
Debt Equity	$0.16
Equity	$107.2M
Liabilities	$30.4M
Long Term Assets	$19.2M
Long Term Liabilities	$13.7M
Net Cash	$97.7M
Net Cash By Market Cap	$12.46
Net Cash Growth	-10.78%
Net Debt Equity	$-0.91
Tangible Book Value	$107.2M
Tangible Book Value Per Share	$1.67
WACC	6.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.09
Net Working Capital	$-9.7M
Quick ratio	6.87
Working Capital	$101.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	4.71%
200-day SMA	6.37
3Y total return	-39.64%
50-day SMA	6.97
50-day SMA vs 200-day SMA	50over200
All Time High	26.16
All Time High Change	-72.82%
All Time High Date	2021-11-16
All Time Low	4.35
All Time Low Change	63.64%
All Time Low Date	2025-05-15
ATR	0.36
Beta	0.4
Beta1y	1.39
Beta2y	1.65
Ch YTD	30.46
High	7.16
High52	9.54
High52 Date	2026-05-05
High52ch	-25.43%
Low	6.93
Low52	4.73
Low52 Date	2026-01-20
Low52ch	50.32%
Ma50ch	1.99%
Premarket Change Percent	-3
Premarket Price	$6.8
Premarket Volume	318
Price vs 200-day SMA	11.63%
RSI	52.38
RSI Monthly	47.63
RSI Weekly	54.45
Sharpe ratio	0.29x
Sortino ratio	0.59
Total Return	-29.81%
Tr YTD	30.46
Tr1m	3.34%
Tr1w	-1.25%
Tr3m	5.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$23.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.38
Operating Income	$-118.6M
Price target	$18.8
Price Target Change	$164
Price Target Change Top	$231

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	99,541,311%
Float Percent	90.25%
Shares Insiders	1.11%
Shares Institutions	42.94%
Shares Out	110,299,428
Shares Qo Q	0.52%
Shares Yo Y	29.81%
Short Float	5.63%
Short Ratio	7.8
Short Shares	5.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-106.3M
Adjusted OCF	-105,907,000
Average Volume	511,568.45x
Bv Per Share	1.67
CAPEX	$-362,000
Ch1m	3.34
Ch1w	-1.25
Ch1y	4.71
Ch3m	5.65
Ch3y	-39.64
Ch6m	29.75
Change	1.43%
Change From Open	0.28
Close	7.01
Days Gap	1.14
Depreciation Amortization	1,112,000
Dollar Volume	2,082,682.5
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-118.6M
EBITDA	$-117.5M
EPS	$-1.74
F Score	1
FCF	$-91.6M
FCF EV Yield	-13.35x
FCF Per Share	$-0.83
Financing CF	77,359,000
Fiscal Year End	December
Founded	2,007
Income Tax	$101,000
Investing CF	60,680,000
Ipr	-49.21
Iprfo	-49.57
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	6.51
Ma150ch	9.28%
Ma20	7.06
Ma20ch	0.65%
Net CF	46,567,000
Next Earnings Date	2026-08-12
Open	7.09
Optionable	Yes
Position In Range	78.26
Ppne	17,888,000
Pre Close	7.01
Price Date	2026-07-30
Ptbv Ratio	7.31
Relative Volume	0.57x
Share Based Comp	14,627,000
Tr6m	29.75%
Us State	Massachusetts
Volume	292,923

Aura Biosciences, Inc. (AURA)

Coverage state: Market snapshot only — no published research

Generate the first AURA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AURA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AURA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AURA

Frequently asked questions